Anupam Rasayan India Q3 FY25 revenue up 30%; Profit up 108%
General

Anupam Rasayan India Q3 FY25 revenue up 30%; Profit up 108%

The Pharma and Polymer segments have emerged as key growth drivers, and continue to strengthen their contribution to the company's revenue

  • By ICN Bureau | February 14, 2025

Anupam Rasayan India Ltd. (ARIL), one of India’s leading custom synthesis and specialty chemical players, total revenue for Q3 FY25 was up 30% YoY at Rs. 386.6 crore as compared to Rs. 297.9 crore in Q3 FY24.

EBITDA (incl. other income) was at Rs. 120.8 crore in Q3 FY25 as compared to Rs. 81.5 crore in Q3 FY24, up 48% and this would translate into 31% EBITDA margin in this quarter. Profit After Tax was at Rs. 54.2 crore in Q3 FY25 as compared to Rs. 26 crore in Q3 FY24, up 108% YoY.

Total revenue for 9M FY25 was at Rs. 942.8 crore as compared to Rs. 1,092.3 crore in 9M FY24 and was down 14% YoY.

EBITDA (incl. other income) was at Rs. 262.4 crore in 9M FY25 as compared to Rs. 306.2 crore in 9M FY24, this would translate into 28% EBITDA margin in 9M FY25. Profit After Tax was at Rs. 970 million in 9M FY25 as compared to Rs. 1,270 crore in 9M FY24.

Speaking on the performance, Anand Desai, Managing Director, Anupam Rasayan commented, “Our Pharma and Polymer segments, which have emerged as key growth drivers, continue to strengthen their contribution to our revenue. Both the segments coupled with strong performance of Tanfac led to significant growth this quarter, fueling a robust 31% QoQ revenue growth in Q3FY25 on a consolidated basis. For the full year, we expect them to play a substantial role in overall revenue, with this upward trend projected to continue into FY26. Additionally, the Agrochemical segment has shown signs of recovery, particularly in the European market."

"With strong demand momentum and expected off-take from our customers, we anticipate regaining our growth trajectory in the next financial year, aiming for a 30-35% revenue increase in FY26," added Desai.

Anupam Rasayan India operates via its six manufacturing facilities in Gujarat, India, with four facilities located at Sachin, Surat and two located at Jhagadia, Bharuch with an aggregate installed capacity of about 30,000 MT, as of December 31, 2024. ARIL offers multistep synthesis and undertakes complex chemical reactions technologies, for a diverse base of Indian and global customers. The company is focussed on developing in-house innovative processes for manufacturing products requiring complex chemistries and achieving cost optimization.

Register Now to Attend Gujarat Chem & Petchem Conference 2025 on May 8-9th 2025, at Hyatt Place, Bharuch

Upcoming Conferences

Gujarat Chem & Petchem Conference 2025

May 08, 2025

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization